FIGO IA2-IB2期宫颈癌孤立性腹主动脉旁淋巴结转移:重新审视手术评估的作用
基于美国国家癌症数据库2011-2014年3212例FIGO IA2-IB2期宫颈癌患者,994例(30.9%)接受腹主动脉旁淋巴结清扫。孤立性腹主动脉旁转移风险为0.11%,盆腔淋巴结评估对腹主动脉旁淋巴结状态的阴性预测值为99.9%(95%CI 99.9-99.9)。行与未行腹主动脉旁淋巴结清扫者总生存无差异(p=0.69)。
要点
- FIGO IA2-IB2期宫颈癌孤立性腹主动脉旁淋巴结转移风险仅0.11%。
- 盆腔淋巴结评估预测腹主动脉旁淋巴结状态的阴性预测值为99.9%。
- 腹主动脉旁淋巴结清扫与未清扫者总生存无差异(p=0.69)。
核心结论
- 对于因FIGO IA2-IB2期宫颈癌行根治性子宫切除术和盆腔淋巴结清扫的患者,基于孤立性转移病变风险低且该手术无生存获益,不推荐行腹主动脉旁淋巴结清扫。
研究设计与样本
- 利用美国国家癌症数据库(NCDB)识别2011-2014年诊断的FIGO IA2-IB2期宫颈鳞癌、腺鳞癌或腺癌患者。
- 共3212例患者符合纳入标准,其中994例(30.9%)接受了腹主动脉旁淋巴结清扫。
- 主要结局为组织学评估的盆腔淋巴结状态对腹主动脉旁淋巴结状态的阴性预测值。
- 比较接受与未接受腹主动脉旁淋巴结清扫患者的总生存。
主要发现
- 在行腹主动脉旁淋巴结清扫的994例患者中,孤立性腹主动脉旁转移风险为0.11%。
- 手术评估的盆腔淋巴结预测腹主动脉旁淋巴结状态的阴性预测值为99.9%(95% CI 99.9-99.9)。
- 93例盆腔淋巴结转移患者中,18例(19.4%)同时存在腹主动脉旁淋巴结转移。
- 行盆腔和腹主动脉旁淋巴结清扫者与仅行盆腔淋巴结清扫者总生存无差异(p=0.69)。
临床怎么用
- 作者认为,对于FIGO IA2-IB2期宫颈癌行根治性子宫切除术和盆腔淋巴结清扫的患者,不推荐行腹主动脉旁淋巴结清扫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the utility of para-aortic lymph node dissection among women undergoing radical hysterectomy and pelvic lymph adenectomy for FIGO Stage IA2-IB2 cervical cancer using the National Cancer Database (NCDB). METHODS: We identified patients with stage IA2-IB2 squamous cell, adenosquamous, or adenocarcinoma of the cervix diagnosed 2011-2014 in the NCDB. The primary outcome was the negative predictive value of histologically assessed pelvic lymph node status for para-aortic lymph node status among women undergoing pelvic and para-aortic lymph node dissection. We calculated probability of para-aortic lymph node metastasis conditional on pelvic lymph node status. Finally, we compared overall survival between patients undergoing para-aortic lymph node dissection and those in whom this procedure was omitted. RESULTS: A total of 3212 patients met study inclusion criteria, of whom 994 (30.9%) underwent para-aortic lymph node dissection. In this group, the risk of isolated para-aortic metastasis was 0.11%. The negative predictive value of surgically assessed pelvic lymph nodes to predict para-aortic lymph node status was 99.9% (95% CI 99.9-99.9). Among 93 patients with pelvic lymph node metastasis, 18 (19.4%) had concurrent para-aortic lymph node metastasis. There was no difference in overall survival between women undergoing pelvic and para-aortic lymph node dissection compared with those undergoing pelvic lymphadenectomy only (p = 0.69). CONCLUSIONS: In patients undergoing radical hysterectomy and pelvic lymphadenectomy for stage IA2-IB2 cervical cancer, para-aortic lymph node dissection is not warranted based on the low risk of isolated metastatic disease, and lack of survival benefit associated with the procedure.
引用
- Del Carmen MG, Pareja R, Melamed A, et al. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment. Gynecol Oncol. 2018. PMID: 30017539. doi:10.1016/j.ygyno.2018.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。